Baystate Wealth Management LLC Novo Nordisk A S Transaction History
Baystate Wealth Management LLC
- $1.36 Billion
- Q4 2023
A detailed history of Baystate Wealth Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Baystate Wealth Management LLC holds 1,246 shares of NVO stock, worth $98,172. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,246
Previous 581
114.46%
Holding current value
$98,172
Previous $52,000
146.15%
% of portfolio
0.01%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding NVO
# of Institutions
1,885Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.57 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.22 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.02 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$996 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$962 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $178B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...